• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类白细胞抗原-DPB1 配合度由其表达水平和错配宽容度决定:德国多中心分析。

The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.

机构信息

Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, and University Hospital Ulm, Ulm, Germany.

Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.

出版信息

Front Immunol. 2021 Jan 25;11:614976. doi: 10.3389/fimmu.2020.614976. eCollection 2020.

DOI:10.3389/fimmu.2020.614976
PMID:33569061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7868530/
Abstract

T-cell epitope matching according to the TCE3 algorithm classifies HLA-DPB1 mismatches in permissive and non-permissive. This classification has been shown to be predictive for mortality and acute GvHD (aGvHD) events in large international cohorts. We retrospectively genotyped HLA-DPB1 in 3523 patients transplanted in Germany between 2000 and 2014 and in their unrelated donors using an Illumina amplicon-NGS based assay. Aim of the study was to evaluate DP-compatibility beyond the established TCE3 algorithm by assessing the combined effect of several DP-mismatch parameters on post-transplant outcome. We implemented an extended DP-mismatch assessment model where TCE3, DP allotype expression with respect to rs9277534, mismatch vector and number of mismatches were conjointly taken into consideration. In this model, non-permissive HLA-DPB1 mismatches showed significantly increased aGvHD risk if they were accompanied by two HLA-DPB1 mismatches in GvH direction (HR: 1.46) or one mismatched highly expressed patient allotype (HR: 1.53). As previously reported, non-permissive HLA-DPB1 mismatches associated with a significantly higher risk of aGvHD and non-relapse mortality (HR 1.36 and 1.21, respectively), which in turn translated into worse GvHD and relapse free survival (HR 1.13). Effects on GvL and GvHD appeared strongest in GvH-directed non-permissive mismatches. Our study results support the consideration of additional HLA-DPB1 mismatch parameters along with the established TCE3 matching algorithm for refinement of future donor selection. In particular, our findings suggest that DP non-permissiveness associated with two HLA-DPB1 mismatches or at least on highly expressed mismatched patient allotype should be avoided.

摘要

根据 TCE3 算法进行 T 细胞表位匹配,将 HLA-DPB1 错配分为允许性和非允许性。这一分类在大型国际队列中已被证明对死亡率和急性移植物抗宿主病(aGvHD)事件具有预测性。我们回顾性地对 2000 年至 2014 年在德国接受移植的 3523 名患者及其无关供者进行了 HLA-DPB1 基因分型,使用了基于 Illumina 扩增子-NGS 的检测方法。该研究的目的是通过评估几个 DP 错配参数对移植后结果的综合影响,评估 TCE3 算法之外的 DP 相容性。我们实施了一个扩展的 DP 错配评估模型,其中 TCE3、与 rs9277534 相关的 DP 同种异型表达、错配向量和错配数量被联合考虑。在这个模型中,如果非允许性 HLA-DPB1 错配伴随着两个移植物抗宿主病方向的 HLA-DPB1 错配(HR:1.46)或一个错配的高度表达患者同种异型(HR:1.53),则会显著增加 aGvHD 风险。与之前的报道一致,非允许性 HLA-DPB1 错配与 aGvHD 和非复发死亡率显著相关(HR 分别为 1.36 和 1.21),这反过来又导致 aGvHD 和无复发生存(HR 分别为 1.13)恶化。在移植物抗宿主病方向的非允许性错配中,对 GvL 和 GvHD 的影响最为明显。我们的研究结果支持在未来的供者选择中,考虑额外的 HLA-DPB1 错配参数与既定的 TCE3 匹配算法相结合,以进一步细化。特别是,我们的研究结果表明,应避免与两个 HLA-DPB1 错配或至少与高度表达的错配患者同种异型相关的 DP 非允许性。

相似文献

1
The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.人类白细胞抗原-DPB1 配合度由其表达水平和错配宽容度决定:德国多中心分析。
Front Immunol. 2021 Jan 25;11:614976. doi: 10.3389/fimmu.2020.614976. eCollection 2020.
2
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.无关供者造血细胞移植受者 HLA-DPB1 中 T 细胞表位匹配的效果:一项回顾性研究。
Lancet Oncol. 2012 Apr;13(4):366-74. doi: 10.1016/S1470-2045(12)70004-9. Epub 2012 Feb 15.
3
Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.10/10 HLA 配型相合的无关供受者配对中 HLA-DPB1 错配对异基因干细胞移植后临床结局的影响。
Eur J Haematol. 2017 Sep;99(3):275-282. doi: 10.1111/ejh.12916. Epub 2017 Jul 21.
4
HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.在非亲缘造血干细胞移植项目中,HLA-DPB1配型会导致疾病复发率升高。
Hum Immunol. 2017 Nov;78(11-12):665-671. doi: 10.1016/j.humimm.2017.08.008. Epub 2017 Sep 5.
5
HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation.单份脐带血移植后,HLA-DPB1 错配诱导移植物抗白血病效应而无严重急性移植物抗宿主病。
Leukemia. 2018 Jan;32(1):168-175. doi: 10.1038/leu.2017.202. Epub 2017 Jun 27.
6
Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation.HLA-DPB1 等位基因的进化基础影响无关供者造血干细胞移植中的急性移植物抗宿主病。
Blood. 2018 Feb 15;131(7):808-817. doi: 10.1182/blood-2017-08-801449. Epub 2017 Dec 15.
7
HLA-DPB1 and DPA1 ~ DPB1 linkage mismatch affects the survival of recipients receiving HLA-14/14 matched unrelated donor HSCT.HLA-DPB1 和 DPA1~DPB1 连锁错配影响 HLA-14/14 匹配的无关供者 HSCT 受者的生存。
HLA. 2024 Jun;103(6):e15542. doi: 10.1111/tan.15542.
8
Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation.剖析 HLA-DPB1 表达的遗传控制及其与造血干细胞移植中结构不匹配模型的关系。
Front Immunol. 2018 Oct 5;9:2236. doi: 10.3389/fimmu.2018.02236. eCollection 2018.
9
Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.无关供者骨髓移植中HLA位点匹配的生物学意义
Blood. 2015 Feb 12;125(7):1189-97. doi: 10.1182/blood-2014-10-604785. Epub 2014 Dec 17.
10
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.HLA-DPB1 T细胞表位匹配与非亲缘造血细胞移植结果之间的风险关联独立于HLA-DPA1。
Bone Marrow Transplant. 2014 Sep;49(9):1176-83. doi: 10.1038/bmt.2014.122. Epub 2014 Jun 23.

引用本文的文献

1
HLA Linked Regional Differences in Donor Selection: A 9-Year Study of the Swiss Registry.供体选择中与HLA相关的区域差异:对瑞士登记处的一项9年研究
Transfus Med Hemother. 2023 Jun 16;50(6):539-546. doi: 10.1159/000530580. eCollection 2023 Dec.
2
Host versus graft HLA-DP1 mismatching promotes graft versus host disease.宿主与移植物的HLA - DP1错配会促进移植物抗宿主病。
Bone Marrow Transplant. 2023 Aug;58(8):950-952. doi: 10.1038/s41409-023-02003-6. Epub 2023 May 6.
3
Assessment of HLA-DPB1 genetic variation using an HLA-DP tool and its implications in clinical transplantation.

本文引用的文献

1
Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.HLA-DP 表达在异基因供体移植后移植物抗宿主病中的作用。
J Clin Oncol. 2020 Aug 20;38(24):2712-2718. doi: 10.1200/JCO.20.00265. Epub 2020 Jun 1.
2
HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.HLA-DP 错配和 CMV 再激活独立增加异基因干细胞移植受者发生移植物抗宿主病的风险。
Curr Res Transl Med. 2019 May;67(2):51-55. doi: 10.1016/j.retram.2019.01.001. Epub 2019 Jan 23.
3
Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects.
采用 HLA-DP 工具评估 HLA-DPB1 基因变异及其在临床移植中的意义。
Blood Adv. 2023 Sep 12;7(17):4809-4821. doi: 10.1182/bloodadvances.2022009554.
4
Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation.HLA 免疫肽组对异基因供体移植后白血病患者生存的影响。
J Clin Oncol. 2023 May 1;41(13):2416-2427. doi: 10.1200/JCO.22.01229. Epub 2023 Jan 20.
5
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation.整合生物性人类白细胞抗原-DPB1错配模型以预测非亲缘造血细胞移植后的生存率。
Haematologica. 2023 Feb 1;108(2):645-652. doi: 10.3324/haematol.2021.280055.
6
Distribution of HLA-A, -B, -C, -DRB1, -DQB1, -DPB1 allele frequencies in patients with COVID-19 bilateral pneumonia in Russians, living in the Chelyabinsk region (Russia).俄罗斯车里雅宾斯克地区 COVID-19 双肺炎患者 HLA-A、-B、-C、-DRB1、-DQB1、-DPB1 等位基因频率分布。
Hum Immunol. 2022 Jul;83(7):547-550. doi: 10.1016/j.humimm.2022.04.009. Epub 2022 Apr 28.
7
Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.I 类/II 类 HLA 进化分歧比是异基因造血干细胞移植治疗急性髓系白血病后无病生存和总生存的独立标志物。
Front Immunol. 2022 Mar 4;13:841470. doi: 10.3389/fimmu.2022.841470. eCollection 2022.
8
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation.基于非亲缘移植中HLA - DPB1差异预测临床结局的生物学模型分析
Blood Adv. 2021 Sep 14;5(17):3377-3386. doi: 10.1182/bloodadvances.2020003998.
从时变效应的角度看造血干细胞移植后的竞争风险结局。
Haematologica. 2018 Sep;103(9):1527-1534. doi: 10.3324/haematol.2017.183012. Epub 2018 Jun 7.
4
Hidden genomic MHC disparity between HLA-matched sibling pairs in hematopoietic stem cell transplantation.造血干细胞移植中 HLA 匹配的同胞对之间隐藏的基因组 MHC 差异。
Sci Rep. 2018 Mar 29;8(1):5396. doi: 10.1038/s41598-018-23682-y.
5
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.非受者 HLA-DPB1 错配对体外 T 细胞耗竭的无关异基因移植后的影响。
Blood. 2018 Mar 15;131(11):1248-1257. doi: 10.1182/blood-2017-07-798751. Epub 2018 Jan 31.
6
Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 32,000 samples.基于标准DPB1基因分型预测HLA-DPB1表达标志物:超过32000个样本的连锁分析
Hum Immunol. 2018 Jan;79(1):20-27. doi: 10.1016/j.humimm.2017.11.001. Epub 2017 Nov 7.
7
Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.10/10 HLA 配型相合的无关供受者配对中 HLA-DPB1 错配对异基因干细胞移植后临床结局的影响。
Eur J Haematol. 2017 Sep;99(3):275-282. doi: 10.1111/ejh.12916. Epub 2017 Jul 21.
8
Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.非相容 HLA-DPB1 T 细胞表位组错配的方向性不能改善 8/8 匹配的无关供者造血细胞移植中的临床风险分层。
Bone Marrow Transplant. 2017 Sep;52(9):1280-1287. doi: 10.1038/bmt.2017.96. Epub 2017 Jun 5.
9
How to select the best available related or unrelated donor of hematopoietic stem cells?如何选择最佳的造血干细胞相关或无关供体?
Haematologica. 2016 Jun;101(6):680-7. doi: 10.3324/haematol.2015.141119. Epub 2016 May 31.
10
One million haemopoietic stem-cell transplants: a retrospective observational study.一百万例造血干细胞移植:一项回顾性观察研究。
Lancet Haematol. 2015 Mar;2(3):e91-100. doi: 10.1016/S2352-3026(15)00028-9. Epub 2015 Feb 27.